1-2 of 2
Kiwamu Okita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Masafumi Ikeda, Takuji Okusaka, Shuichi Mitsunaga, Hideki Ueno, Toshiyuki Tamai, Takuya Suzuki, Seiichi Hayato, Tadashi Kadowaki, Kiwamu Okita, Hiromitsu Kumada
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (6): 1385–1394.
https://doi.org/10.1158/1078-0432.CCR-15-1354
Published: 14 March 2016
View article titled, Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
Open the PDF for Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Preventive Effect of FK143, a 5α-Reductase Inhibitor, on Chemical Hepatocarcinogenesis in Rats

Seiji Maruyama, Naofumi Nagasue, Dipok Kumar Dhar, Akira Yamanoi, Osama N. El-Assal, Kimihiko Satoh, Kiwamu Okita
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (7): 2096–2104.
Published: 01 July 2001
View article titled, Preventive Effect of FK143, a 5α-Reductase Inhibitor, on Chemical Hepatocarcinogenesis in Rats
Open the PDF for Preventive Effect of FK143, a 5α-Reductase Inhibitor, on Chemical Hepatocarcinogenesis in Rats in another window